BR9202771A - Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera - Google Patents

Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera

Info

Publication number
BR9202771A
BR9202771A BR929202771A BR9202771A BR9202771A BR 9202771 A BR9202771 A BR 9202771A BR 929202771 A BR929202771 A BR 929202771A BR 9202771 A BR9202771 A BR 9202771A BR 9202771 A BR9202771 A BR 9202771A
Authority
BR
Brazil
Prior art keywords
blood
microsphere
compounds
introduce
compound
Prior art date
Application number
BR929202771A
Other languages
English (en)
Inventor
Susan Mancini Cady
William David Steber
Philip Wayne Hayes
Mary Ehlers Doscher
Kurt Allen Schwinghammer
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of BR9202771A publication Critical patent/BR9202771A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR929202771A 1991-07-23 1992-07-20 Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera BR9202771A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73443091A 1991-07-23 1991-07-23

Publications (1)

Publication Number Publication Date
BR9202771A true BR9202771A (pt) 1993-03-23

Family

ID=24951666

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929202771A BR9202771A (pt) 1991-07-23 1992-07-20 Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera

Country Status (21)

Country Link
US (1) US6340671B1 (pt)
EP (1) EP0525307B1 (pt)
JP (1) JP3470904B2 (pt)
KR (1) KR100235550B1 (pt)
CN (1) CN1046852C (pt)
AT (1) ATE134873T1 (pt)
AU (1) AU651229B2 (pt)
BR (1) BR9202771A (pt)
CA (1) CA2074348C (pt)
DE (1) DE69208765T2 (pt)
DK (1) DK0525307T3 (pt)
ES (1) ES2086022T3 (pt)
GR (1) GR3019234T3 (pt)
HK (1) HK1000005A1 (pt)
HU (1) HU220595B1 (pt)
IE (1) IE74401B1 (pt)
IL (1) IL102567A (pt)
MX (1) MX9204135A (pt)
NZ (1) NZ243619A (pt)
TW (1) TW201696B (pt)
ZA (1) ZA925522B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5643595A (en) * 1992-11-24 1997-07-01 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
DE4308282C2 (de) * 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
TR200103188T2 (tr) * 1999-05-07 2002-04-22 Pharmasol Gmbh Sıvı ve katı lipit karışımları temelli lipid parçacıklar.
US8663692B1 (en) * 1999-05-07 2014-03-04 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
DE60133706T2 (de) * 2000-10-10 2009-07-02 Wyeth Holdings Corp. Stabilisierte Arzneizusammensetzungen zur parenteralen Vearbreichung
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
MX2012004133A (es) 2009-10-07 2012-05-08 Wyeth Llc Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.
ITUB20153652A1 (it) * 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
HUE065367T2 (hu) 2017-04-13 2024-05-28 Ceva Sante Animale Parazitafertõzések kezelésére használható injektálható anyag
BR112021016432A2 (pt) 2019-02-21 2021-11-09 Chromadex Inc Composição que compreende prills de cera, processo para produzir prills de cera, composição nutricional, alimento, bebida ou suplemento alimentar que compreende prills de cera, e composição que compreende microesferas encapsuladas
EP3962448A1 (en) 2019-05-03 2022-03-09 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
AU2021277491B2 (en) 2020-05-20 2024-05-16 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
WO2022263505A1 (en) * 2021-06-16 2022-12-22 Société des Produits Nestlé S.A. Methods of solid phase wax coating of an active ingredient
US20260014227A1 (en) 2022-06-30 2026-01-15 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction
WO2025190964A1 (en) 2024-03-12 2025-09-18 Virbac Parenteral modoflaner for the control of ectoparasites
US20260021076A1 (en) 2024-07-22 2026-01-22 Zoetis Services Llc Isoxazoline and macrocyclic lactone microspheres
WO2026041795A1 (en) 2024-08-23 2026-02-26 Intervet International B.V. Injectable veterinary composition for cattle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3659022A (en) * 1967-11-13 1972-04-25 Upjohn Co Methods of preventing impregnation
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US5106994A (en) * 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
US5169956A (en) * 1984-06-05 1992-12-08 American Cyanamid Company Macrolide antibiotic compounds
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
DK0385106T3 (da) * 1989-02-28 1994-04-11 American Cyanamid Co Bolus med forhalet frigivelse effektiv til forlænget prævention eller behandling af eller kontrol med nematode-, mide- og endo- og ektoparasitiske infektioner hos drøvtyggere
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5192546A (en) * 1991-01-15 1993-03-09 Mycogen Corporation Synergistic pesticidal compositions
US5346698A (en) * 1991-01-15 1994-09-13 Mycogen Corporation Synergistic pesticidal compositions
US5185108A (en) * 1991-07-10 1993-02-09 The B. F. Goodrich Company Method for producing wax microspheres
JP4654917B2 (ja) 2006-01-12 2011-03-23 日産自動車株式会社 車体後部構造

Also Published As

Publication number Publication date
KR930001904A (ko) 1993-02-22
ZA925522B (en) 1993-04-28
JP3470904B2 (ja) 2003-11-25
NZ243619A (en) 1994-12-22
KR100235550B1 (ko) 1999-12-15
CN1068735A (zh) 1993-02-10
ATE134873T1 (de) 1996-03-15
HU9202404D0 (en) 1992-10-28
HK1000005A1 (en) 1997-10-03
EP0525307B1 (en) 1996-03-06
DE69208765T2 (de) 1996-09-26
TW201696B (pt) 1993-03-11
EP0525307A1 (en) 1993-02-03
HUT62454A (en) 1993-05-28
AU2047292A (en) 1993-01-28
CA2074348C (en) 2004-02-17
DK0525307T3 (da) 1996-04-01
ES2086022T3 (es) 1996-06-16
IL102567A (en) 1996-10-31
HU220595B1 (hu) 2002-03-28
DE69208765D1 (de) 1996-04-11
IE74401B1 (en) 1997-07-30
JPH05194211A (ja) 1993-08-03
US6340671B1 (en) 2002-01-22
CA2074348A1 (en) 1993-01-24
MX9204135A (es) 1993-01-01
CN1046852C (zh) 1999-12-01
IE922373A1 (en) 1993-01-27
GR3019234T3 (en) 1996-06-30
IL102567A0 (en) 1993-01-14
AU651229B2 (en) 1994-07-14

Similar Documents

Publication Publication Date Title
MX9204135A (es) Composiciones estables para administracion parenteral y procedimiento para su preparacion.
PT2013119442B (pt) Composições veterinárias orais parasiticidas compreendendo agentes activos de actuação sistémica, métodos e as suas utilizações
IE44980L (en) Pour-on anthelmintic formulations
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
AU781682B2 (en) Sustained-release compositions for parenteral administration
BRPI0406875A (pt) Derivados de monossacarìdeo de avermectina tendo propriedades pesticidas
BR0016430A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
DE69331007D1 (de) Difluoroavermectin-derivate
BRPI0407271A (pt) Composição anti-helmìntica
ES2132283T3 (es) Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
DE3573707D1 (de) Anticoccidial compostions
KR950703956A (ko) 순환 장애 개선제[circulatory disturbance ameliorant]
FR2534809B1 (fr) Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
PT1100463E (pt) Novas formulacoes injectaveis contendo ramoplanina
AU2006203347C1 (en) Stabilised formulation
DK0505389T3 (da) Antiparasitisk præparat til animalsk anvendelse
BR0016427A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal